A simplified method for the generation of human osteoclasts in vitro

International Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 2, 2011, Pages 183-189

  Cody, James J ^a   Rivera, Angel A ^b   Liu, Jianzhong ^a   Liu, Jillian M ^c   Douglas, Joanne T ^b,d   Feng, Xu ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow; Bone resorption; Human; In vitro; Osteoclast; Protocol

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT COLONY STIMULATING FACTOR 1;

ARTICLE; BONE MARROW CELL; CELL FUNCTION; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICAL BONE; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; IN VITRO STUDY; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; TISSUE SLICE;

MURINAE;

EID: 79958070197     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-1508.
2. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R and Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.
3. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci U S A 1998; 95: 3597-3602.
4. Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP and Teitelbaum SL. A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function. J Clin Invest 2001; 107: 1137-1144.
5. Nardelli B, Zaritskaya L, McAuliffe W, Ni Y, Lincoln C, Cho YH, Birse CE, Halpern W, Ullrich S and Moore PA. Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cells. Endocrinology 2006; 147: 70-78.
6. Susa M, Luong-Nguyen NH, Cappellen D, Zamurovic N and Gamse R. Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay. J Transl Med 2004; 2: 6.
7. Quinn JM, Neale S, Fujikawa Y, McGee JO and Athanasou NA. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998; 62: 527-531.
8. Flanagan AM and Massey HM. Generating human osteoclasts in vitro from bone marrow and peripheral blood. Methods Mol Med 2003; 80: 113-128.
9. Takahashi N, Kukita T, MacDonald BR, Bird A, Mundy GR, McManus LM, Miller M, Boyde A, Jones SJ and Roodman GD. Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest 1989; 83: 543-550.
10. Hughes DE, MacDonald BR, Russell RG and Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989; 83: 1930-1935.
11. Heymann D, Gouin F, Guicheux J, Munevar JC, Godard A and Daculsi G. Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF). Cytokine 1997; 9: 46-52.
12. Sarma U and Flanagan AM. Macrophage colony -stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 1996; 88: 2531- 2540.
13. Oreffo RO, Kusec V, Virdi AS, Flanagan AM, Grano M, Zambonin-Zallone A and Triffitt JT. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage. Histochem Cell Biol 1999; 111: 125-133.
14. Lader CS, Scopes J, Horton MA and Flanagan AM. Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression. Br J Haematol 2001; 112: 430- 437.
15. Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM and Zannettino AC. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum- free medium. J Cell Physiol 2005; 203: 573-582.
16. Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC and Cohen-Solal ME. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures. Eur Cytokine Netw 2002; 13: 39-45.
17. Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM and Amling M. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 2004; 25: 3963- 3972.
18. Sarma U, Edwards M, Motoyoshi K and Flanagan AM. Inhibition of bone resorption by 17beta-estradiol in human bone marrow cultures. J Cell Physiol 1998; 175: 99-108.
19. Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ and Roodman GD. Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res 2005; 20: 1161-1167.
20. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO and Teitelbaum SL. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000; 105: 433-440.